FSHR and neoplasm: While post-OHE hypergonadotropinism has been linked to certain non-reproductive tumors [12,13,15,16,17,18], systematic investigations into LHR/FSHR expression patterns in CMTs and their correlations with tumor malignancy or spay status remain absent, significantly impeding risk assessment and therapeutic development based on gonadotropin signaling.